Comparative Risk and Policy Analysis in Environmental Health

There is increasing interest in the integration of quantitative risk analysis with benefit-cost and cost-effectiveness methods to evaluate environmental health policy making and perform comparative analyses. However, the combined use of these methods has revealed deficiencies in the available methods, and the lack of useful analytical frameworks currently constrains the utility of comparative risk and policy analyses. A principal issue in integrating risk and economic analysis is the lack of common performance metrics, particularly when conducting comparative analyses of regulations with disparate health endpoints (e.g., cancer and noncancer effects or risk-benefit analysis) and quantitative estimation of cumulative risk, whether from exposure to single agents with multiple health impacts or from exposure to mixtures. We propose a general quantitative framework and examine assumptions required for performing analyses of health risks and policies. We review existing and proposed risk and health-impact metrics for evaluating policies designed to protect public health from environmental exposures, and identify their strengths and weaknesses with respect to their use in a general comparative risk and policy analysis framework. Case studies are presented to demonstrate applications of this framework with risk-benefit and air pollution risk analyses. Through this analysis, we hope to generate discussions regarding the data requirements, analytical approaches, and assumptions required for general models to be used in comparative risk and policy analysis.

[1]  F. Guillemin The value of utility: assumptions underlying preferences and quality adjusted life years. , 1999, The Journal of rheumatology.

[2]  Lorenz R. Rhomberg,et al.  A survey of methods for chemical health risk assessment among federal regulatory agencies , 1997 .

[3]  M L Dourson,et al.  Regulatory history and experimental support of uncertainty (safety) factors. , 1983, Regulatory toxicology and pharmacology : RTP.

[4]  J. Sundby Are women disfavoured in the estimation of Disability Adjusted Life Years and the Global Burden of Disease? , 1999, Scandinavian journal of public health.

[5]  E. Faustman,et al.  Quality adjusted life years (QALYs) and dose-response models in environmental health policy analysis -- methodological considerations. , 2001, The Science of the total environment.

[6]  Division on Earth Ranking Hazardous-Waste Sites for Remedial Action , 1994 .

[7]  A. Dyer,et al.  Fish consumption and the 30-year risk of fatal myocardial infarction. , 1997, The New England journal of medicine.

[8]  C. Cox,et al.  Fetal methylmercury poisoning. Relationship between concentration in single strands of maternal hair and child effects. , 1987, Archives of neurology.

[9]  M. Johannesson,et al.  Are Healthy-years Equivalents an Improvement over Quality-adjusted Life Years? , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[10]  Robert Fabian,et al.  Valuing health for policy : an economic approach , 1995 .

[11]  Income-related inequality in life-years and quality-adjusted life-years. , 2000, Journal of health economics.

[12]  G L Kimmel,et al.  Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  E. Nord,et al.  The value of DALY life: problems with ethics and validity of disability adjusted life years , 1999, BMJ.

[14]  K S Crump,et al.  A new method for determining allowable daily intakes. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[15]  E M Faustman,et al.  Use of Quality‐Adjusted Life Year Weights with Dose‐Response Models for Public Health Decisions: A Case Study of the Risks and Benefits of Fish Consumption , 2000, Risk analysis : an official publication of the Society for Risk Analysis.

[16]  Vlasta Molak,et al.  Fundamentals of Risk Analysis and Risk Management , 1996 .

[17]  Elaine M. Faustman,et al.  Review of noncancer risk assessment: Applications of benchmark dose methods , 1997 .

[18]  C. Kimmel,et al.  Quantitative approaches to human risk assessment for noncancer health effects. , 1990, Neurotoxicology.

[19]  C. Kimmel,et al.  Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[20]  J. Swaney The Basic Economics of Risk Analysis , 1996 .

[21]  J. L. Pinto,et al.  Incorporating societal concerns for fairness in numerical valuations of health programmes. , 1999, Health economics.

[22]  R. Zerbe,et al.  Benefit-cost analysis in theory and practice , 2002 .

[23]  Division on Earth Risk Assessment in the Federal Government: Managing the Process , 1983 .

[24]  Leslie Lenert,et al.  Validity and Interpretation of Preference-Based Measures of Health-Related Quality of Life , 2000, Medical care.

[25]  J Tsevat,et al.  What do utilities measure? , 2000, Medical care.